Humana Inc.

NYSE: HUM · Real-Time Price · USD
286.66
5.32 (1.89%)
At close: Aug 15, 2025, 3:59 PM
286.85
0.07%
After-hours: Aug 15, 2025, 05:31 PM EDT

Humana Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
4.04B 4.25B 2.22B 5.12B 5.5B 5.91B 4.69B 15.15B 16.21B 13.73B 5.06B 13.56B 5.15B 4.86B 3.39B 4.3B 3.38B 3.88B
Short-Term Investments
17.67B 17.89B 18.21B 19.03B 17.42B 16.7B 16.63B 15.14B 15.25B 14.93B 13.88B 13.12B n/a n/a n/a n/a n/a n/a
Long-Term Investments
431M 410M 421M 400M 736M 730M -16.27B 762M 733M 739M -13.51B 738M n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
-13.37B 4.04B 1.5B 4.4B 30.54B 29.96B 43.81B 26.11B 25.61B 26.73B 36.01B 23.1B 27.88B 24.46B 23.48B 24.65B 26.75B 26.09B
Receivables
4.5B 4.46B 2.7B 2.14B 4.09B n/a 2.04B 1.82B 1.43B 3.11B 1.67B 1.61B n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a -36.95B -36.72B -32.02B -40.08B -40.19B -40.64B -27.86B -35.32B n/a n/a n/a n/a n/a n/a
Other Current Assets
n/a 7.83B n/a 6.63B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Current Assets
33.62B 34.42B 23.14B 32.93B 5.5B 5.91B 4.69B 15.15B 16.21B 13.73B 5.06B 13.56B 5.15B 4.86B 3.39B 4.3B 3.38B 3.88B
Property-Plant & Equipment
2.36B 2.43B 2.98B 2.69B 2.82B 2.98B 3.54B 3.34B 3.31B 3.23B 3.74B 3.22B 3.12B 3.19B 3.75B 2.9B 2.69B 2.51B
Goodwill & Intangibles
11.01B 9.63B 11.07B 9.59B 11.23B 11.24B 11.24B 11.3B 11.32B 11.07B 10.91B 10.89B 10.67B 13.79B 13.73B 13.46B 5.26B 4.95B
Total Long-Term Assets
16.74B 16.51B 16.66B 17.08B 44.59B 44.18B 42.37B 40.76B 40.24B 41.04B 37.99B 37.21B 41.67B 41.44B 40.96B 41.02B 34.69B 33.54B
Total Assets
50.36B 50.93B 46.48B 50.01B 50.09B 50.09B 47.06B 55.91B 56.45B 54.78B 43.05B 50.77B 46.82B 46.31B 44.36B 45.32B 38.07B 37.41B
Account Payables
n/a 16.83B 15.7B 5.92B 17.97B 6.17B 16.81B 17.8B 7.66B 7.03B 4.94B 6.53B n/a n/a n/a n/a n/a n/a
Deferred Revenue
274M n/a 260M n/a 313M n/a 266M 7.54B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
n/a 577M 577M 1.14B 1.15B 822M 1.44B 2.25B 2.02B 1.87B 2.09B 2.8B 1.54B 1.69B 1.95B 795M 1.11B 1.2B
Other Current Liabilities
n/a 265M n/a 11.68B 313M -7.33B 266M 7.54B 18.14B 17.64B 9.85B 15.49B -1.93B -2.01B -2.28B -1.03B -1.34B -1.55B
Total Current Liabilities
17.22B 18.04B 16.94B 18.73B 19.79B 19.69B 18.87B 27.82B 28.28B 26.94B 17.18B 25.05B n/a n/a n/a n/a n/a n/a
Long-Term Debt
12.59B 12.73B 11.14B 11.89B 11.75B 12.39B 10.21B 9.48B 9.72B 9.74B 9.03B 7.8B 11.29B 11.29B 10.54B 11.47B 6.06B 6.06B
Other Long-Term Liabilities
-12.59B 2.34B 2.61B 1.77B 1.83B 1.83B 1.66B n/a n/a n/a 1.47B n/a 20.02B 19.68B 17.71B 17.57B 17.16B 17.16B
Total Long-Term Liabilities
14.84B 15.07B 13.76B 13.66B 11.75B 12.39B 10.21B 9.48B 9.72B 9.74B 9.03B 7.8B 11.29B 11.29B 10.54B 11.47B 6.06B 6.06B
Total Liabilities
32.06B 33.11B 30.03B 32.38B 11.75B 12.39B 10.21B 9.48B 9.72B 9.74B 9.03B 7.8B 11.29B 11.29B 10.54B 11.47B 6.06B 6.06B
Total Debt
12.59B 13.31B 11.72B 13.02B 12.89B 13.21B 12.27B 11.97B 12.2B 12.02B 11.42B 10.83B 13.22B 13.29B 12.82B 12.5B 7.41B 7.61B
Common Stock
33M 33M 33M 33M 33M 33M 33M 33M 33M 33M 33M 33M 33M 33M 33M 33M 33M 33M
Retained Earnings
29.89B 29.45B 28.32B 29.12B 28.75B 28.17B 27.54B 28.19B 27.47B 26.62B 25.49B 25.61B 24.51B 23.91B 23.09B 23.19B 21.75B 21.25B
Comprehensive Income
-783M -868M -1.07B -653M -1.12B -1.09B -999M -1.5B -1.23B -1.11B -1.3B -1.47B -1.05B -572M 42M 145M 216M 108M
Shareholders Equity
18.23B 17.75B 16.38B 17.57B 16.67B 16.13B 16.26B 16.95B 16.83B 16.58B 15.31B 16.25B 15.49B 15.32B 16.08B 16.26B 14.84B 14.19B
Total Investments
n/a 18.3B 18.64B 19.43B 18.16B 17.43B 358M 16.28B 16.37B 16.04B 15.01B 14.24B 13.59B 13.62B 14.11B 14.96B 15.89B 15.58B